SYDNEY, Feb 4 (Bernama-GLOBE NEWSWIRE) — George Clinical announces that the organization has been accredited by the Australian Office of the Gene Technology Regulator (OGTR) which allows it to be a licence holder for studies involving the use of genetically modified organisms (GMOs).
The addition of this capability means that George Clinical can now, under the Gene Technology Act 2000 and Gene Technology Regulations 2001, undertake DIR (dealings involving intentional release) and DNIR (dealings not involving intentional release) licensing and execute studies inclusive of the required writing of DIR and DNIR applications as well as IBC (Institutional Biosafety Committee) review. Being OGTR accredited enables George Clinical to hold a license in the name of a sponsoring company.
- Lebanese Minister Warns Against Interaction With Israeli Accounts On Social Media
- Sudan crisis: New wave of mass killings alarms UN
- Egyptian, Iranian FMs Discussed Developments Of Israel’s Attacks On Iran
- Egypt Proposes Two-Day Gaza Ceasefire Initiative For Hostage-Prisoner Swap: President
- UN Security Council emergency meeting Monday after Iran request
- Japan’s Ruling Coalition On Edge As LDP Falls Short Of Majority In General Election
- Uzbekistan Held First Mixed-System Parliamentary Election
- NPP Secures First Local Election Victory For Nov Parliamentary Vote In Sri Lanka
- Israeli Regime Completed Airstrike On Iranian Targets, Tehran Reported “Limited Damage”
- Voting For Japan’s Lower House Election Starts In Tightening Races